| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.90B | -5.7% |
| Gross Profit | $269.0M | -47.8% |
| R&D Expense | $15.0M | +7.1% |
| SG&A Expense | $290.0M | -2.0% |
| Operating Income | -$253.0M | -215.5% |
| Interest Expense | $189.0M | +13.2% |
| Pre-tax Income | -$458.0M | -727.4% |
| Income Tax | $15.0M | -88.2% |
| Net Income | -$470.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $199.0M | +31.8% |
| Accounts Receivable | $289.0M | +8.6% |
| Inventory | $1.65B | +6.5% |
| Current Assets | $2.27B | +5.1% |
| Total Assets | $6.22B | +3.0% |
| Current Liabilities | $919.0M | +5.1% |
| Long-term Debt | $3.13B | +13.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $60.0M | -80.0% |
| Investing Cash Flow | -$328.0M | +4.4% |
| Financing Cash Flow | $321.0M | +552.1% |
| -879.2% |
| EPS (Basic) | -$2.97 | -858.1% |
| EPS (Diluted) | -$2.97 | -858.1% |
| Total Liabilities |
| $4.77B |
| +12.3% |
| Stockholders' Equity | $1.42B | -19.5% |